Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
NT 10-Q/A
Notice of late quarterly filing (amended)
30 Oct 23
ARS
2022 FY
Annual report to shareholders
2 Oct 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
Current reports
8-K
Entry into a Material Definitive Agreement
18 Apr 24
8-K
Departure of Directors or Certain Officers
16 Apr 24
8-K
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
6 Mar 24
8-K
Adial Announces Appointment of Tony Goodman as Chief Operating Officer
18 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
16 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
28 Nov 23
8-K
Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
14 Nov 23
8-K
Departure of Directors or Certain Officers
6 Nov 23
8-K/A
Completion of Acquisition or Disposition of Assets
30 Oct 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
18 Apr 24
S-3
Shelf registration
12 Apr 24
D
$287.50 k in equity / options / securities to be acquired, sold $287.50 k, 1 investor
14 Mar 24
424B5
Prospectus supplement for primary offering
25 Jan 24
S-3
Shelf registration
12 Jan 24
S-8
Registration of securities for employees
12 Dec 23
424B3
Prospectus supplement
20 Nov 23
S-1
IPO registration
8 Nov 23
D
$4.00 mm in equity / options / securities to be acquired, sold $4.00 mm, 1 investor
26 Oct 23
424B3
Prospectus supplement
28 Jul 23
Proxies
DEFA14A
Additional proxy soliciting materials
14 Dec 23
DEF 14A
Definitive proxy
8 Dec 23
PRE 14A
Preliminary proxy
24 Nov 23
DEF 14A
Definitive proxy
29 Sep 23
DEFA14A
Additional proxy soliciting materials
29 Mar 23
DEF 14A
Definitive proxy
6 Mar 23
PRE 14A
Preliminary proxy
24 Feb 23
DEF 14A
Definitive proxy
1 Sep 22
DEFR14A
Revised proxy
26 Aug 21
DEF 14A
Definitive proxy
23 Aug 21
Other
EFFECT
Notice of effectiveness
25 Jan 24
CORRESP
Correspondence with SEC
22 Jan 24
UPLOAD
Letter from SEC
19 Jan 24
EFFECT
Notice of effectiveness
20 Nov 23
CORRESP
Correspondence with SEC
15 Nov 23
UPLOAD
Letter from SEC
14 Nov 23
EFFECT
Notice of effectiveness
28 Jul 23
CORRESP
Correspondence with SEC
25 Jul 23
CORRESP
Correspondence with SEC
13 Jul 23
UPLOAD
Letter from SEC
7 Jul 23
Ownership
4
Robertson H. Gilliland
27 Mar 24
4
James W. Jr. Newman
27 Mar 24
4
Joseph Truluck
27 Mar 24
4
Cary J Claiborne
27 Mar 24
4
J. Kermit Anderson
27 Mar 24
4
Kevin Schuyler
27 Mar 24
4
Tony Goodman
27 Mar 24
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Kevin Schuyler
3 Oct 23
4
Bankole A. Johnson
2 Jun 23